Should the Concern of Myelodysplastic Syndrome Affect the Decision of Auto-SCT in Lymphoma?

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2009.156
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Primary Central Nervous System Lymphoma: Implication of High-Dose Chemotherapy Followed by Auto-SCT

Bone Marrow Transplantation
TransplantationHematology
2011English

Prognostic Value of Comorbidity for Auto-SCT Eligibility and Outcome in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2010English

Chronic GVHD Induced GVL Effect After Unmanipulated Haploidentical Hematopoietic SCT for AML and Myelodysplastic Syndrome

Bone Marrow Transplantation
TransplantationHematology
2014English

Could Haemochromatosis ( HFE ) Gene Mutations Affect Response to Iron Chelation in Myelodysplastic Syndrome?

British Journal of Haematology
Hematology
2019English

Incidence of Myelodysplastic Syndrome in Japan

Journal of Epidemiology
MedicineEpidemiology
2014English

Retrospective Comparison of the Effects of Filgrastim and Pegfilgrastim on the Pace of Engraftment in Auto-SCT Patients

Bone Marrow Transplantation
TransplantationHematology
2010English

Matched-Pair Analysis to Compare the Outcomes of a Second Salvage Auto-SCT to Systemic Chemotherapy Alone in Patients With Multiple Myeloma Who Relapsed After Front-Line Auto-SCT

Bone Marrow Transplantation
TransplantationHematology
2012English

Transplantation for Myelodysplastic Syndrome in the Era of Hypomethylating Agents

Current Opinion in Hematology
Hematology
2012English

The Current Perspective of Low-Grade Myelodysplastic Syndrome in Children

International Journal of Hematology
Hematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy